Decryption – Technology turned out to be safe and promising in five patients with severe symptoms.
The five patients, aged 23 to 75, had signs of severe depression that conventional drugs had not been able to relieve. As part of a clinical trial conducted in 2023 at the Sainte-Anne hospital in Paris, they tested a new therapy based on the concentration of ultrasound of low intensity in a specific region of the brain. Preliminary results, published Monday in the journal Brain Stimulation, Leave hoping for an advance in the management of resistant depression, a disease against which doctors are today quite helpless.
Innourity of the technique
No serious side effects have been reported and the MRIs made after the sessions confirmed the safety of the technique. Emitted at low intensity, ultrasound do not result in a locally temperature elevation. “Participants did not feel or heard the waves”specifies the Dr David Attali, chief of assistant clinic at Paris Cité and co -author of the pilot study.
” It’s necessary…
This article is reserved for subscribers. You have 81% to discover.
I am inquiring, I inspire myself, I subscribe.
Discover our welcome offer.
Already subscribed? Connect